{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:21Z","timestamp":1790289081562,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"INSERM, the French National Research Agency","award":["ANR 12-BSV1-0020-01"],"award-info":[{"award-number":["ANR 12-BSV1-0020-01"]}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coi.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T10:32:42Z","timestamp":1504261962000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Hemophagocytic syndrome: primary forms and predisposing conditions"],"prefix":"10.1016","volume":"49","author":[{"given":"Fernando E","family":"Sepulveda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"de Saint Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2017.08.004_bib0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coi.2017.08.004_bib0330","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0335","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0340","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.coi.2017.08.004_bib0345","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2803","article-title":"Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules","volume":"11","author":"de Saint Basile","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.08.004_sbref0350","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.08.004_sbref0355","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3324\/haematol.2014.121608","article-title":"The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis","volume":"100","author":"Bode","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2017.08.004_bib0360","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coi.2017.08.004_bib0365","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.coi.2017.08.004_bib0375","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0380","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0385","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.08.004_bib0390","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pbc.24475","article-title":"Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2\/MUNC18-2 mutations","volume":"60","author":"Stepensky","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.coi.2017.08.004_bib0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with hemophagocytic syndrome","volume":"25","author":"M\u00e9nasch\u00e9","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0400","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng1196-307","article-title":"Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome","volume":"14","author":"Nagle","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0405","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2011-02-339523","article-title":"The munc13-4\u2013rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane","volume":"118","author":"Elstak","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/tra.12244","article-title":"LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function","volume":"16","author":"Sepulveda","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.coi.2017.08.004_bib0415","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2017.00426","article-title":"Differences in granule morphology yet equally impaired exocytosis among cytotoxic T cells and NK cells from Chediak-Higashi Syndrome patients","volume":"8","author":"Chiang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0002-9343(78)90858-6","article-title":"A syndrome associating partial albinism and immunodeficiency","volume":"65","author":"Griscelli","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.coi.2017.08.004_bib0425","first-page":"900","article-title":"Neutropenia cronica maligna familiar con granulaciones atipicas de los leucocitos","volume":"15","author":"Beguez-Cesar","year":"1943","journal-title":"Bol Soc Cubana Pediatr"},{"key":"10.1016\/j.coi.2017.08.004_bib0430","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2005-01-0319","article-title":"Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome","volume":"106","author":"Tardieu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jns.2014.06.026","article-title":"Motor neuronopathy in Chediak-Higashi syndrome","volume":"344","author":"Mathis","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coi.2017.08.004_bib0440","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_sbref0445","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","article-title":"A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice","volume":"125","author":"Sepulveda","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0450","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2012-07-440339","article-title":"Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11","volume":"121","author":"Sepulveda","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0455","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2013.00448","article-title":"Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice","volume":"4","author":"Jessen","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0460","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1073\/pnas.0903815106","article-title":"Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer","volume":"106","author":"Chia","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.08.004_bib0465","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/cdd.2009.212","article-title":"Perforin deficiency and susceptibility to cancer","volume":"17","author":"Brennan","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2017.08.004_sbref0470","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1182\/blood-2015-12-688960","article-title":"Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice","volume":"127","author":"Sepulveda","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0475","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.08.004_bib0480","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [see comments]","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0485","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.coi.2017.08.004_bib0490","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.coi.2017.08.004_bib0495","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0500","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10875-014-0083-7","article-title":"XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0505","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2017.08.004_bib0510","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2017.08.004_bib0515","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coi.2015.01.010","article-title":"The NAIP\/NLRC4 inflammasomes","volume":"32","author":"Vance","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.04.031","article-title":"Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers","volume":"134","author":"Aguilar","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0525","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","article-title":"XIAP deficiency syndrome in humans","volume":"39","author":"Latour","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.coi.2017.08.004_bib0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","article-title":"X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis","volume":"149","author":"Speckmann","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_sbref0535","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","article-title":"XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation","volume":"7","author":"Yabal","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2017.08.004_bib0540","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2013-06-510743","article-title":"cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner","volume":"123","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0545","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1182\/blood-2011-01-329607","article-title":"Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice","volume":"117","author":"Krebs","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0550","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2017.08.004_bib0555","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00431-014-2338-y","article-title":"Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation","volume":"173","author":"Taurisano","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.coi.2017.08.004_bib0560","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13023-016-0550-8","article-title":"Update on lysinuric protein intolerance, a multi-faceted disease retrospective cohort analysis from birth to adulthood","volume":"12","author":"Mauhin","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.coi.2017.08.004_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.05.039","article-title":"Hemophagocytic lymphohistiocytosis as presenting manifestation of profound combined immunodeficiency due to an ORAI1 mutation","author":"Klemann","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_sbref0570","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jaci.2014.11.030","article-title":"Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-gamma receptor deficiency","volume":"135","author":"Tesi","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.004_bib0575","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.coi.2017.08.004_bib0580","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2017.08.004_bib0585","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","article-title":"Macrophage activation syndrome complicating adult onset Still's disease: a single center case series and comparison with literature","volume":"45","author":"Lenert","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2017.08.004_bib0590","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.08.004_bib0595","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2017.08.004_bib0600","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.13462","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents","volume":"170","author":"Lehmberg","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2017.08.004_bib0605","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.coi.2017.08.004_bib0610","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/pbc.22688","article-title":"Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia","volume":"56","author":"Kelly","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.coi.2017.08.004_bib0615","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2017.08.004_bib0620","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","article-title":"Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)","volume":"119","author":"Pagel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coi.2017.08.004_bib0625","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies","volume":"43","author":"Rudd","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.coi.2017.08.004_sbref0630","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1016\/S2352-3026(15)00223-9","article-title":"Cancer risk in relatives of patients with a primary disorder of lymphocyte cytotoxicity: a retrospective cohort study","volume":"2","author":"Lofstedt","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.coi.2017.08.004_bib0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.638","article-title":"Viral infections associated with haemophagocytic syndrome","volume":"20","author":"Maakaroun","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coi.2017.08.004_bib0640","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI116721","article-title":"Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome","volume":"92","author":"Kawaguchi","year":"1993","journal-title":"J Clin Invest"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:33Z","timestamp":1760604213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":64,"alternative-id":["S0952791517301152"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2017.08.004","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophagocytic syndrome: primary forms and predisposing conditions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}